Cantor Fitzgerald Reaffirms “Buy” Rating for Sabra Healthcare REIT, Inc. (SBRA)

Cantor Fitzgerald restated their buy rating on shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in a report issued on Friday. They currently have a $30.00 price target on the real estate investment trust’s stock. Cantor Fitzgerald also issued estimates for Sabra Healthcare REIT’s FY2017 earnings at $2.27 EPS and FY2018 earnings at $2.31 EPS.

“We expect investors to be pleased that SBRA’s restructuring of selected underperforming leases acquired in last months combination with CCP appears to eliminate the poor coverage issues at Signature and other operators, and demonstrate substantially more accretion from CCP than we had assumed.”,” Cantor Fitzgerald’s analyst wrote.

A number of other equities analysts also recently commented on the company. Zacks Investment Research downgraded Sabra Healthcare REIT from a hold rating to a sell rating in a research report on Thursday, June 8th. BidaskClub downgraded Sabra Healthcare REIT from a sell rating to a strong sell rating in a research report on Wednesday, August 16th. JMP Securities upgraded Sabra Healthcare REIT from a market perform rating to an outperform rating and set a $23.00 price objective on the stock in a research report on Tuesday, September 5th. Jefferies Group LLC reiterated a hold rating and set a $28.00 price objective on shares of Sabra Healthcare REIT in a research report on Friday, May 12th. Finally, Mizuho reiterated a neutral rating on shares of Sabra Healthcare REIT in a research report on Wednesday, June 28th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of $25.00.

Sabra Healthcare REIT (NASDAQ:SBRA) opened at 22.78 on Friday. Sabra Healthcare REIT has a 12-month low of $19.30 and a 12-month high of $29.10. The company has a 50-day moving average price of $22.39 and a 200-day moving average price of $24.78. The stock has a market capitalization of $1.49 billion, a PE ratio of 19.18 and a beta of 0.89.

WARNING: This piece was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece on another site, it was stolen and republished in violation of international copyright & trademark laws. The legal version of this piece can be viewed at https://sportsperspectives.com/2017/09/11/cantor-fitzgerald-reaffirms-buy-rating-for-sabra-healthcare-reit-inc-sbra.html.

The firm also recently announced a quarterly dividend, which was paid on Friday, August 18th. Shareholders of record on Wednesday, August 16th were given a $0.3599 dividend. The ex-dividend date was Monday, August 14th. This represents a $1.44 dividend on an annualized basis and a yield of 6.32%. Sabra Healthcare REIT’s dividend payout ratio is currently 122.03%.

Large investors have recently bought and sold shares of the business. Phocas Financial Corp. grew its stake in shares of Sabra Healthcare REIT by 4.7% in the second quarter. Phocas Financial Corp. now owns 212,756 shares of the real estate investment trust’s stock valued at $5,127,000 after buying an additional 9,470 shares in the last quarter. Cetera Investment Advisers acquired a new stake in shares of Sabra Healthcare REIT in the second quarter valued at $505,000. Wasatch Advisors Inc. grew its stake in shares of Sabra Healthcare REIT by 14.5% in the second quarter. Wasatch Advisors Inc. now owns 570,029 shares of the real estate investment trust’s stock valued at $13,738,000 after buying an additional 72,125 shares in the last quarter. Koch Industries Inc. acquired a new stake in shares of Sabra Healthcare REIT in the second quarter valued at $739,000. Finally, Piedmont Investment Advisors LLC acquired a new stake in shares of Sabra Healthcare REIT in the second quarter valued at $340,000. Institutional investors own 99.26% of the company’s stock.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply